Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Phase III trial of cabozantinib meets primary endpoint

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

MolMed expands phase III trial of NGR-hTNF

Oct. 25, 2011

Study establishes hENT1 cutoff level for LEAP trial

Oct. 25, 2011

Cell Therapeutics resubmits pixantrone NDA

Oct. 25, 2011

Novel B-raf inhibitors disclosed by Boehringer Ingelheim

Oct. 25, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...